[Translation] A randomized, double-blind, placebo-controlled, parallel study of revefenacin nebulized solution in Chinese subjects with moderate to very severe chronic obstructive pulmonary disease (COPD)
在中国中度至极重度 COPD 受试者人群中,证实与安慰剂相比,revefenacin 吸入用溶液 175 mcg 每日一次雾化治疗 12 周的有效性
[Translation] Efficacy of revefenacin inhalation solution 175 mcg once-daily nebulized treatment compared with placebo in a Chinese population of moderate to very severe COPD subjects for 12 weeks